7-nitroindazole protects striatal dopaminergic neurons against MPP+-induced degeneration: an in vivo microdialysis study (Q48293950)

10 February 2018

title

7-nitroindazole protects striatal dopaminergic neurons against MPP+-induced degeneration: an in vivo microdialysis study (English)

1 reference

10 February 2018

1 reference

1 reference

7

1 reference

10 February 2018

author name string

Vincenzo Di Matteo

1

1 reference

10 February 2018

Arcangelo Benigno

2

1 reference

10 February 2018

Massimo Pierucci

3

1 reference

10 February 2018

Davide Antonio Giuliano

4

1 reference

10 February 2018

Giuseppe Crescimanno

5

1 reference

10 February 2018

Ennio Esposito

6

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 November 2006

1 reference

10 February 2018

Annals of the New York Academy of Sciences

published in

1 reference

10 February 2018

volume

1089

1 reference

10 February 2018

page(s)

462-471

1 reference

10 February 2018

Striatal dopamine deficiency in Parkinson's disease: role of aging

cites work

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.015

Genes, proteins, and neurotoxins involved in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.015

Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.015

Role of nitric oxide synthase against MPTP neurotoxicity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.015

Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.015

Impairment of the neuronal dopamine transporter activity in MPP(+)-treated rat was not prevented by treatments with nitric oxide synthase or poly(ADP-ribose) polymerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.015

Brain dialysis in conscious rats reveals an instantaneous massive release of striatal dopamine in response to MPP+.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.015

Nitric oxide modulates striatal neuronal activity via soluble guanylyl cyclase: an in vivo microiontophoretic study in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.015

Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.015

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.015

Ageing and neurotoxins as causative factors in idiopathic Parkinson's disease--a critical analysis of the neurochemical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.015

Parkinson's disease. First of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.015

Reserpine prevents hydroxyl radical formation by MPP+ in rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.015

Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.015

Non-steroidal anti-inflammatory drug sodium salicylate, but not diclofenac or celecoxib, protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.015

Inhibitory effect of nitric oxide on dopamine transporters: interneuronal communication without receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.015

L-arginine increases dopamine transporter activity in rat striatum via a nitric oxide synthase-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.015

The neuronal nitric oxide synthase inhibitor 7-nitroindazole also inhibits the monoamine oxidase-B-catalyzed oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.015

Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.015

Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.015

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1386.015

1 reference

10 February 2018

1 reference

10 February 2018